Cephalon Sued For Delaying Generic Competition
The suit, filed by the Pennsylvania Turnpike Commission (PTC), accused Cephalon of unlawfully excluding generic competition from the market for modafinil, the active ingredient in Provigil.
“Cephalon engineered a conspiracy to restrain trade, and a scheme to monopolize the [modafinil market] by substantially delaying the onset of generic competition for its top selling...
Already a subscriber? Click here to login